Aadi Bioscience (AADI) Short Interest Ratio & Short Volume → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free AADI Stock Alerts $1.68 -0.10 (-5.62%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Aadi Bioscience Short Interest DataCurrent Short Volume1,100,000 sharesPrevious Short Volume943,100 sharesChange Vs. Previous Month+16.64%Dollar Volume Sold Short$2.09 millionShort Interest Ratio / Days to Cover3.2Last Record DateApril 15, 2024Outstanding Shares24,550,000 sharesFloat Size17,440,000 sharesShort Percent of Float6.31%Today's Trading Volume166,465 sharesAverage Trading Volume360,936 sharesToday's Volume Vs. Average46% Short Selling Aadi Bioscience ? Sign up to receive the latest short interest report for Aadi Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAADI Short Interest Over TimeAADI Days to Cover Over TimeAADI Percentage of Float Shorted Over Time Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Aadi Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,100,000 shares $2.09 million +16.6%6.3%3.2 $1.90 3/31/2024943,100 shares $2.21 million -16.5%5.4%2.4 $2.34 3/15/20241,130,000 shares $2.45 million +19.0%6.5%2.6 $2.17 2/29/2024949,300 shares $1.87 million -4.1%5.5%1.7 $1.97 2/15/2024990,300 shares $1.88 million -13.1%5.7%2.2 $1.90 1/31/20241,140,000 shares $2.10 million +29.1%6.6%2.7 $1.84 Get the Latest News and Ratings for AADI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024883,200 shares $1.52 million +7.4%5.1%2.2 $1.72 12/31/2023822,200 shares $1.66 million +29.3%4.8%2.3 $2.02 12/15/2023635,900 shares $1.49 million -19.4%3.7%2.1 $2.34 11/30/2023789,000 shares $4.15 million +6.1%4.6%7.1 $5.26 11/15/2023743,700 shares $3.50 million -1.7%4.3%7 $4.71 10/31/2023756,600 shares $3.31 million -5.6%4.4%7 $4.38 10/15/2023801,300 shares $3.39 million +9.1%4.7%6.2 $4.23 9/30/2023734,700 shares $3.56 million +10.8%4.3%5.4 $4.84 9/15/2023662,900 shares $3.67 million +6.4%3.9%4.6 $5.54 8/31/2023623,300 shares $3.93 million -5.1%3.7%4.5 $6.30 8/15/2023656,500 shares $3.91 million -39.8%3.9%4.8 $5.95 7/31/20231,090,000 shares $5.81 million -4.4%6.4%8 $5.33 7/15/20231,140,000 shares $6.54 million +9.6%6.7%9 $5.74 6/30/20231,040,000 shares $7.11 million -14.1%6.1%8.6 $6.84 6/15/20231,210,000 shares $9.92 million +11.0%7.2%9.3 $8.20 5/31/20231,090,000 shares $8.72 million -15.5%6.5%8.5 $8.00 5/15/20231,290,000 shares $9.07 million +17.3%7.7%9 $7.03 4/30/20231,100,000 shares $8.54 million -2.7%6.8%7.3 $7.76 4/15/20231,130,000 shares $9.14 million -27.6%7.0%8 $8.09 3/31/20231,560,000 shares $11.29 million +7.6%9.7%11.5 $7.24 3/15/20231,450,000 shares $11.63 million +22.9%9.0%12.1 $8.02 2/28/20231,180,000 shares $12.71 million +6.3%7.3%11.3 $10.77 2/15/20231,110,000 shares $13.18 million +2.8%6.9%11.8 $11.87 1/31/20231,080,000 shares $13.63 million +3.9%6.4%12.9 $12.62 1/15/20231,040,000 shares $13.47 million -11.9%6.1%11.7 $12.95 12/30/20221,180,000 shares $15.14 million +12.4%7.0%13.6 $12.83 12/15/20221,050,000 shares $13.34 million No Change6.2%11.6 $12.70 11/30/20221,050,000 shares $14.05 million -0.9%6.2%9.6 $13.38 11/15/20221,060,000 shares $14.21 million +13.0%6.3%9.2 $13.41 10/31/2022937,900 shares $12.11 million +27.6%6.1%8 $12.92 10/15/2022735,100 shares $9.27 million -2.1%5.5%6.2 $12.61 9/30/2022750,600 shares $10.61 million +2.0%5.6%6 $14.13 9/15/2022735,800 shares $9.39 million +5.6%6.3%4.5 $12.76 8/31/2022696,800 shares $9.44 million +8.9%6.0%4.6 $13.55These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy AADI Short Interest - Frequently Asked Questions What is Aadi Bioscience's current short interest? Short interest is the volume of Aadi Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,100,000 shares of AADI short. 6.31% of Aadi Bioscience's shares are currently sold short. Learn More on Aadi Bioscience's current short interest. What is a good short interest ratio for Aadi Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AADI shares currently have a short interest ratio of 3.0. Learn More on Aadi Bioscience's short interest ratio. Which institutional investors are shorting Aadi Bioscience? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aadi Bioscience: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aadi Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.31% of Aadi Bioscience's floating shares are currently sold short. Is Aadi Bioscience's short interest increasing or decreasing? Aadi Bioscience saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 1,100,000 shares, an increase of 16.6% from the previous total of 943,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aadi Bioscience's float size? Aadi Bioscience currently has issued a total of 24,550,000 shares. Some of Aadi Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aadi Bioscience currently has a public float of 17,440,000 shares. How does Aadi Bioscience's short interest compare to its competitors? 6.31% of Aadi Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aadi Bioscience: Clene Inc. (0.12%), NextCure, Inc. (0.54%), Eledon Pharmaceuticals, Inc. (0.13%), Jaguar Health, Inc. (5.20%), CalciMedica, Inc. (0.71%), Rockwell Medical, Inc. (2.40%), Bolt Biotherapeutics, Inc. (8.63%), Apollomics, Inc. (0.32%), Ocuphire Pharma, Inc. (6.37%), Xilio Therapeutics, Inc. (4.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Aadi Bioscience stock? Short selling AADI is an investing strategy that aims to generate trading profit from Aadi Bioscience as its price is falling. AADI shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aadi Bioscience? A short squeeze for Aadi Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AADI, which in turn drives the price of the stock up even further. How often is Aadi Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AADI, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Clene Short Interest Data NextCure Short Interest Data Eledon Pharmaceuticals Short Interest Data Jaguar Health Short Interest Data CalciMedica Short Interest Data Rockwell Medical Short Interest Data Bolt Biotherapeutics Short Interest Data Apollomics Short Interest Data Ocuphire Pharma Short Interest Data Xilio Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AADI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press